Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1) , 15-26
- https://doi.org/10.1053/sonc.2002.31524
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Epidermal growth factor-related peptides and their receptors in human malignanciesPublished by Elsevier ,2000
- Signaling—2000 and BeyondCell, 2000
- Epidermal growth factor receptors: critical mediators of multiple receptor pathwaysPublished by Elsevier ,1999
- Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1999
- Specificity within the EGF family/ErbB receptor family signaling networkBioEssays, 1998
- Trans-Activation of Epidermal Growth Factor Receptor Gene by the Hepatitis B Virus X-Gene ProductVirology, 1993
- The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survivalBritish Journal of Cancer, 1993
- Transforming Growth Factor Alpha, Shope Fibroma Growth Factor, and Vaccinia Growth Factor Can Replace Myxoma Growth Factor in the Induction of Myxomatosis in RabbitsVirology, 1993
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984